Scopolamine Market Analysis

Dosage Form (Tablet, Syrup, Injection, Patch)

The global scopolamine market is segmented and analyzed for demand and supply by dosage form into tablet, syrup, injection, patch, and others. Out of these, the patch segment is estimated to gain the largest market share of about 28% in the year 2037. The growth of the segment can be attributed to the increasing use of transdermal patches in patients suffering from postoperative symptoms such as nausea. The occurrence of nausea and vomiting in the high-risk patients was high and was estimated to be over 18%-28% after surgery as per the estimations in 2019. The increasing use of transdermal patches in chemotherapy treatments is estimated to fuel the market segment growth during the forecast period. The transdermal patches are attached to the hair-free area on the skin such as the back of the ears. The growing number of people suffering from cancer and cancer-related disorders is estimated to hike the market segment growth. The increasing application in people suffering from diabetes to prevent dizziness during low sugar levels is estimated to drive the market segment growth. Also, the market segment growth is attributed to the increasing use in patients suffering from Parkinson-like disorders.

Distribution Channel (Hospital, Retail, Online Pharmacies)

The global scopolamine market is also segmented and analyzed for demand and supply by distribution channel into hospital, retail, online pharmacies, and others. Amongst these three segments, the hospital pharmacies segment is expected to garner a significant share of around 30% in the year 2036. The easy availability of hospital pharmacies and the growing patient population in the hospitals are driving the market segment growth. The increasing number of people with stomach and gastrointestinal disorders such as spastic muscle states, diverticulitis, and irritable bowel syndrome admitted in hospitals is estimated to propel the market growth. The incidence of irritable bowel syndrome (IBS) in a greater number of people is also propelling the market growth. More than 9%-13% of the people in the U.S. are estimated to suffer from IBS with women having a higher rate of incidence than men as of 2022. The changing food habits and lifestyle affecting the gastric system and digestive system of people is anticipated to fuel the market segment growth.

Our in-depth analysis of the global market includes the following segments: